The synthesis and exocrine level of IL-6 in myocardial tissue and peripheral blood can be inhibited by the TMS-induced inhibition of IL-1β, and therefore, TMS could have a potential role in treating and improving PAH. The gene discussed is IL1B; the disease is pulmonary arterial hypertension.